INTEGRILIN

In the US, INTEGRILIN (eptifibatide systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat Acute Coronary Syndrome, Angina, Heart Attack and Percutaneous Coronary Intervention.

US matches:

• Integrilin

UK matches:

• Integrilin 2mg solution for injection, 0.75mg solution for infusion (SPC)

Ingredient matches for INTEGRILIN

Eptifibatide

Eptifibatide is reported as an ingredient of INTEGRILIN in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Bulgaria


• Canada


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Thailand


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.